Institutional Longevity Medicine Platform with Enterprise Scalability

Asking Price$675,213

Cash Flow

EBITDANot Disclosed

Gross Revenue$1,369,190

InventoryNot Disclosed

FF&ENot Disclosed

Real EstateNot Disclosed

listing imageSave

Institutional Longevity Medicine Platform with Enterprise Scalability


Asking Price$675,213

Cash Flow

EBITDANot Disclosed

Gross Revenue$1,369,190

InventoryNot Disclosed

FF&ENot Disclosed

Real EstateNot Disclosed

Business Description
This institutional longevity medicine platform delivers frontier biological reprogramming through next-generation multi-omic analysis and combinatorial age reversal protocols.

Category-defining advantages:

- Third-generation epigenetic clocks with single-cell resolution aging phenotyping
- Exclusively-licensed therapeutics targeting twelve senescence intervention axes
- Enterprise clinical trial infrastructure enabling geographic replication at scale
- Institutional capital acquisition platforms driving ultra-premium patient acquisition
- Engineered for scalable dominance within $50T+ human lifespan engineering paradigm
Listing Info
ID
2481039
Listing Views
7

Contact Seller

By clicking the button, you agree to BizQuest's Terms of Use and Privacy Notice.

Listing ID: 2481039 The information on this listing has been provided by either the seller or a business broker representing the seller. BizQuest has no interest or stake in the sale of this business and has not verified any of the information and assumes no responsibility for its accuracy, veracity, or completeness. See our full Terms of Use. Learn how to avoid scams.


Similar Listings
All About Kids
$150,000All About KidsFeatured Franchise
Body20
$100,000Body20Featured Franchise
101 Mobility
$100,000101 MobilityFeatured Franchise
Established Dental Lab
$1,500,000Established Dental LabColumbus, OH
Success on the Spectrum
$100,000Success on the SpectrumFeatured Franchise
All About Kids
$150,000All About KidsFeatured Franchise
Body20
$100,000Body20Featured Franchise